MOESM3 of Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
收藏Figshare2019-11-27 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/MOESM3_of_Histone_methyltransferases_EHMT1_and_EHMT2_GLP_G9A_maintain_PARP_inhibitor_resistance_in_high-grade_serous_ovarian_carcinoma/11294228
下载链接
链接失效反馈官方服务：
资源简介：
Additional file 3: Tumor Microarray Patient Characteristics (H3K9me2 staining and Kaplan-Meier analysis includes only 92 primary tumors prior to therapy).
创建时间：
2019-11-27
